About
BioAge Labs is a US-based biotechnology company focused on developing therapeutics for cardiometabolic diseases by targeting the biological processes of aging. Their core technology is a human-first discovery platform that leverages decades of proprietary multi-omics data to identify and validate novel aging-related drug targets. Currently, BioAge is advancing BGE-102, a program targeting chronic inflammation, and a preclinical apelin receptor agonist with potential for significant weight loss, both aimed at addressing age-related metabolic dysfunction.
Focus Areas
Technology Focus
healthcare drug discovery ml infrastructure
Quick Stats
Total Raised $183M
Founded 2015
Status private
Type startup
Explore More
Similar Companies
Atomic AI
San Francisco, United States
86%
3 shared categories
3 shared AI types
Same country
Healthcare AIDrug Discovery +1
Valo Health
Boston, United States
82%
3 shared categories
3 shared AI types
Same country
Healthcare AIDrug Discovery +1
54gene
Lagos, Nigeria
79%
3 shared categories
3 shared AI types
Healthcare AIDrug Discovery +1
BenevolentAI
London, United Kingdom
75%
3 shared categories
3 shared AI types
Healthcare AIDrug Discovery +1